Advertisement
Clinical Therapeutics
Advanced searchSave search
Editorial| Volume 17, ISSUE 4, P748, July 1995

Download started.

Ok

Pharmaceutical economics & health policy

Editorial comment
DOI:https://doi.org/10.1016/0149-2918(95)80051-4
Pharmaceutical economics & health policy
Previous ArticleComparison of the efficacy and safety of oxaprozin and nabumetone in the treatment of patients with osteoarthritis of the knee
Next ArticleTwo approaches to comparing hospital charges between cadaveric renal transplant patients who received Orthoclone OKT® 3 sterile solution or Atgam® sterile solution for induction therapy
      This paper is only available as a PDF. To read, Please Download here.

      Article info

      Identification

      DOI: https://doi.org/10.1016/0149-2918(95)80051-4

      Copyright

      © 1995 Published by Elsevier Inc.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX